Subsequent cell-type classification analysis using MCP-counter corroborated the stronger immune correlation of RNF220 in AML and identified decreased CD8+ T cells and increased endothelial cells in patients with high RNF220 expression (Figures 3g, h). Here, RNF220 is linked to acute myeloid leukemia.